当前位置:主页 > 医学论文 > 内分泌论文 >

参芪降糖颗粒辅助治疗2型糖尿病性膝关节炎的临床观察

发布时间:2018-01-31 06:23

  本文关键词: 参芪降糖颗粒 辅助治疗 型糖尿病性膝关节炎 疗效 安全性 出处:《中国药房》2016年24期  论文类型:期刊论文


【摘要】:目的:观察参芪降糖颗粒辅助治疗2型糖尿病性膝关节炎的疗效和安全性。方法:62例2型糖尿病性膝关节炎患者随机分为对照组(31例)和观察组(31例)。对照组患者均给予降糖、针对关节炎的基础治疗,包括饮食控制、运动疗法及健康教育,同时口服盐酸二甲双胍片0.25g,每日3次,餐中服用+阿卡波糖片50mg,每日3次,餐中嚼服;关节炎疼痛患者服用阿司匹林肠溶片100mg,每日1次,饭后口服(不可嚼碎或掰开服用)。观察组患者在对照组治疗的基础上给予参芪降糖颗粒3g,每日3次,餐前半小时用50ml温水冲服。两组疗程均为6个月。观察两组患者的临床疗效,治疗前后的空腹血糖(FPG)、餐后2h血糖(2hPG)、糖化血红蛋白(HbA1c)、白细胞介素(IL)-1β、IL-6及不良反应发生情况。结果:观察组患者总有效率显著高于对照组,差异有统计学意义(P0.05)。治疗前,两组患者FPG、2hPG、HbA_1c、IL-1β、IL-6水平比较,差异均无统计学意义(P0.05)。治疗后,两组患者FPG、2hPG、HbA1c、IL-1β、IL-6水平均显著低于同组治疗前,且观察组低于对照组,差异均有统计学意义(P0.05)。两组患者不良反应发生率比较,差异无统计学意义(P0.05)。结论:在常规治疗的基础上,参芪降糖颗粒辅助治疗2型糖尿病性膝关节炎的疗效显著,可降低血糖及炎症因子水平,且不良反应症状轻微。
[Abstract]:Objective: to observe the efficacy and safety of Shenqi Jiangtang granule in the treatment of type 2 diabetic knee arthritis. Methods: 62 cases of type 2 diabetic knee arthritis were randomly divided into control group (n = 31) and observation group (n = 31). 31 patients in the control group were treated with hypoglycemia. Basic treatment for arthritis, including diet control, exercise therapy and health education, at the same time oral metformin hydrochloride tablets 0.25g, 3 times a day, eat 50 mg of acarbose tablets, 3 times a day. A chewy dress in a meal; Patients with arthritis pain took aspirin enteric-coated tablets 100 mg once a day, oral after meals (not chewed or broken up to take). The patients in the observation group were given Shenqi Jiangtang granule 3 g on the basis of treatment in the control group. Three times a day, half an hour before meal with 50ml warm water. The course of treatment in both groups was 6 months. The clinical effects of the two groups were observed, the fasting blood glucose before and after treatment, 2 h postprandial blood glucose and 2 hPGs were observed. Results: the total effective rate of the patients in the observation group was significantly higher than that in the control group. The difference was statistically significant (P 0.05). Before treatment, the levels of IL-1 尾 and IL-6 were compared between the two groups. There was no significant difference between the two groups (P 0.05). After treatment, the levels of IL-1 尾 and IL-6 in the two groups were significantly lower than those in the same group. And the observation group was lower than the control group, the difference was statistically significant (P 0.05). There was no significant difference in the incidence of adverse reactions between the two groups. Conclusion: on the basis of routine treatment. Shenqi Jiangtang granule was effective in the treatment of type 2 diabetic knee arthritis. It could reduce the level of blood sugar and inflammatory factors, and the adverse reaction was mild.
【作者单位】: 天津医科大学研究生院;唐山市工人医院;
【分类号】:R587.2;R684
【正文快照】: [11]胡汛,张凡,周礼湘.华蟾素胶囊联合支气管动脉化疗栓塞治疗中晚期中央型肺癌临床研究[J].浙江中西医结合杂志,2012,22(4):278.[12]张存良.华蟾素穴位注射治疗顽固性呃逆的临床疗效观察[J].中医临床研究,2014,5(3):42.[13]崔灵芝,张丽皎,王学英.华蟾素治疗肿瘤患者顽固性呃

【相似文献】

相关期刊论文 前10条

1 于兆秀;;参芪降糖颗粒治疗磺脲类药物继发性失效糖尿病38例疗效分析[J];工企医刊;2003年05期

2 刘卫卫;史训忠;林茵华;;参芪降糖颗粒治疗2型糖尿病90例[J];江西中医药;2008年02期

3 叶卓丁;吴钧俊;;参芪降糖颗粒治疗2型糖尿病疗效分析[J];实用中医药杂志;2009年12期

4 董学锋;;参芪降糖颗粒治疗2型糖尿病210例的临床效果分析[J];中国农村卫生事业管理;2011年04期

5 明少兰;;参芪降糖颗粒致腓肠肌痉挛1例[J];医药导报;2012年05期

6 ;参芪降糖颗粒[J];中国药物滥用防治杂志;1996年04期

7 任广来,王济梅,杨洪峰,崔志红;参芪降糖颗粒治疗2型糖尿病81例报告[J];山东医药;1999年17期

8 裴智梅;;参芪降糖颗粒辅助治疗2型糖尿病的疗效[J];中国老年学杂志;2014年16期

9 杨桂云,刘文庆,张博;参芪降糖颗粒治疗Ⅱ型糖尿病152例[J];中医研究;2002年04期

10 林家欢;胡华娟;;参芪降糖颗粒对糖耐量异常患者血糖、血脂的影响[J];现代医院;2007年08期

相关会议论文 前1条

1 饶线明;;参芪降糖颗粒治疗2型糖尿病32例临床观察[A];第七次中国中西医结合糖尿病学术会议论文汇编[C];2004年

相关重要报纸文章 前1条

1 副主任医师 陈海明;参芪降糖颗粒[N];家庭医生报;2003年

相关硕士学位论文 前3条

1 杨才顺;参芪降糖颗粒对早期糖尿病肾病大鼠肾组织ERK通路的影响及作用机制研究[D];安徽中医药大学;2015年

2 张涛会;参芪降糖颗粒治疗早期糖尿病肾病的临床疗效观察[D];广州中医药大学;2012年

3 彭伟;参芪降糖颗粒治疗2型糖尿病气阴两虚证的临床研究[D];北京中医药大学;2012年



本文编号:1478448

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/nfm/1478448.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户ef273***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com